Literature DB >> 2998773

Cell type-specific transcriptional enhancement in vitro requires the presence of trans-acting factors.

H R Schöler, P Gruss.   

Abstract

Cell-specific transcriptional enhancement was observed, depending on the enhancer sequences, using nuclear extracts prepared from B-cells, T-cells and HeLa cells. SV40 enhancer stimulated in vitro transcription up to 15-fold in all three cell extracts, whereas transcriptional potentiation in vitro by IgC mu and LPV enhancers was only seen in B- and T-cell extracts. Thus, the cell type specificity seen in vivo can be reproduced in vitro. The transcriptional enhancement requires the presence of enhancer sequences in cis and also of a common factor interacting in trans with all three enhancer sequences. Interestingly, first experiments indicate the additional presence of cellular factors in T-cell and most prominently in HeLa cell extracts which can reduce the enhancer activity of C mu and LPV.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998773      PMCID: PMC554611          DOI: 10.1002/j.1460-2075.1985.tb04036.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

1.  A viral enhancer element specifically active in human haematopoietic cells.

Authors:  L Mosthaf; M Pawlita; P Gruss
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

2.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

3.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

Review 4.  Regulation of viral transcription and DNA replication by the SV40 large T antigen.

Authors:  R Tjian
Journal:  Curr Top Microbiol Immunol       Date:  1981       Impact factor: 4.291

5.  Identification of a promoter component involved in positioning the 5' termini of simian virus 40 early mRNAs.

Authors:  P K Ghosh; P Lebowitz; R J Frisque; Y Gluzman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

Review 6.  How the lambda repressor and cro work.

Authors:  M Ptashne; A Jeffrey; A D Johnson; R Maurer; B J Meyer; C O Pabo; T M Roberts; R T Sauer
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

7.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.

Authors:  J L Manley; A Fire; A Cano; P A Sharp; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Selective and accurate initiation of transcription at the Ad2 major late promotor in a soluble system dependent on purified RNA polymerase II and DNA.

Authors:  P A Weil; D S Luse; J Segall; R G Roeder
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

10.  Simian virus 40 tandem repeated sequences as an element of the early promoter.

Authors:  P Gruss; R Dhar; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  56 in total

1.  Complex regulation of the immunoglobulin mu heavy-chain gene enhancer: microB, a new determinant of enhancer function.

Authors:  B Nelsen; T Kadesch; R Sen
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  Regulation of kappa immunoglobulin gene transcription in vitro.

Authors:  R A Currie
Journal:  Nucleic Acids Res       Date:  1990-05-25       Impact factor: 16.971

3.  Induction of lymphomas by the hamster papovavirus correlates with massive replication of nonrandomly deleted extrachromosomal viral genomes.

Authors:  S Scherneck; V Delmas; F Vogel; J Feunteun
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Positive and negative regulation of immunoglobulin gene expression by a novel B-cell-specific enhancer element.

Authors:  J Wang; M Oketani; T Watanabe
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

5.  Identification of a pancreatic beta-cell insulin gene transcription factor that binds to and appears to activate cell-type-specific expression: its possible relationship to other cellular factors that bind to a common insulin gene sequence.

Authors:  J Whelan; S R Cordle; E Henderson; P A Weil; R Stein
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

6.  A transcription factor interacting with the class I gene enhancer is inactive in tumorigenic cell lines which suppress major histocompatibility complex class I genes.

Authors:  U Henseling; W Schmidt; H R Schöler; P Gruss; A K Hatzopoulos
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

7.  Cell-type-specific transcription of an immunoglobulin kappa light chain gene in vitro.

Authors:  J Mizushima-Sugano; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

8.  In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences.

Authors:  R Sen; D Baltimore
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

9.  Negative regulation contributes to tissue specificity of the immunoglobulin heavy-chain enhancer.

Authors:  J L Imler; C Lemaire; C Wasylyk; B Wasylyk
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

10.  Multiple hepatic trans-acting factors are required for in vitro transcription of the human alpha-1-antitrypsin gene.

Authors:  Y Li; R F Shen; S Y Tsai; S L Woo
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.